Table 1. Clinical backgrounds and outcomes of the patients.
| Crohn’s disease | Ulcerative colitis | P value | ||
|---|---|---|---|---|
| Male/female | 35/8 | 18/11 | 0.121a | |
| Age (years), median (IQR) | 29.0 (25.0–37.0) | 39 (28–55) | 0.015b | |
| Body mass index, median (IQR) | 19.4 (17.6–21.9) | 18.9 (17.3–20.1) | 0.424b | |
| Body weight (kg), median (IQR) | 55.2 (51.0–59.5) | 51.5 (44.0–57.8) | 0.052b | |
| Height (cm), median (IQR) | 170 (166–174) | 165 (156–169) | 0.002b | |
| Skeletal muscle index (cm2/m2), median (IQR) | 45.1 (40.4–52.5) | 40.7 (35.7–47.1) | 0.059b | |
| Sarcopenia/non-sarcopenia | 16/27 | 14/15 | 0.489a | |
| Days of admission, median (IQR) | 28.0 (15.5–54.0) | 30.0 (25.0–40.0) | 0.854b | |
| Intestinal resection (yes/no) | 19/24 | 6/23 | 0.071a | |
| Disease type | Ileal/colonic/ileocolonic | 13/4/26 | - | |
| Pancolitis / left-sided | - | 22/7 | ||
| Disease activity | CDAI, median (IQR) | 227 (159–298) | - | |
| Lichtiger score, median (IQR) | - | 12 (10–14) | ||
| Endoscopic activity | SES-CD, median (IQR) | 13 (8–16) | - | |
| UCEIS, median (IQR) | - | 6 (5–7) | ||
| Onodera’s prognostic nutritional index, median (IQR) | 37.2 (32.1–42.3) | 31.2 (27.0–34.7) | 0.005b | |
| Controlling nutritional status, median (IQR) | 6 (3–9) | 8 (6–10) | 0.020b | |
| Subjective global assessment, median (IQR) | 2 (2–3) | 2 (2–3) | 1.000b | |
| Malnutrition universal screening tool, median (IQR) | 2 (1–4) | 3 (2–3) | 0.166b | |
| Nutritional risk screening 2002, median (IQR) | 3 (2–4) | 4 (3–4) | 0.218b | |
| BEE (kcal), median (IQR) | 1417 (1331–1527) | 1394 (1241–1489) | 0.181b | |
| BEE / BW (kcal/kg), median (IQR) | 27.1 (25.3–27.7) | 26.6 (24.5–28.0) | 0.709b | |
| REE (kcal), median (IQR) | 1339 (1246–1590) | 1358 (1275–1486) | 0.865b | |
| REE / BW (kcal/kg), median (IQR) | 26.3 (24.5–28.9) | 28.0 (24.3–29.7) | 0.476b | |
| Respiratory quotient, median (IQR) | 0.80 (0.78–0.85) | 0.74 (0.72–0.83) | 0.082b | |
| Hematocrit (%), median (IQR) | 35.1 (29.7–39.8) | 30.8 (27.8–36.0) | 0.059b | |
| White blood cell count (/μL), median (IQR) | 7,500 (5,700–9,850) | 9,000 (7,500–12,000) | 0.055b | |
| Total lymphocyte count (/μL), median (IQR) | 1,295 (826–1,619) | 1,068 (884–1,527) | 0.584b | |
| Neutrophil / Lymphocyte ratio, median (IQR) | 4.41 (2.72–8.68) | 6.14 (4.54–8.71) | 0.054b | |
| Albumin (g/dL), median (IQR) | 3.0 (2.7–3.4) | 2.6 (2.1–2.9) | 0.002b | |
| Total cholesterol (mg/dL), median (IQR) | 130 (116–151) | 120 (102–147) | 0.502b | |
| C-reactive protein (mg/dL), median (IQR) | 2.82 (0.57–9.49) | 4.30 (2.05–8.39) | 0.165b | |
BW: body weight, CDAI: Crohn’s disease activity index, SES-CD: simple endoscopic score for Crohn’s disease, UCEIS: ulcerative colitis endoscopic index of severity, BEE: basal energy expenditure, REE: resting energy expenditure, IQR: interquartile range. Bold items indicate statistically significant results.
aχ2–test
bMann–Whitney U test.